These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 32238232)

  • 1. [From SARS to COVID-19: pathogens, receptor, pathogenesis and principles of the treatment].
    Wang X; Ding YQ
    Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):647-652. PubMed ID: 32238232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections.
    Zhang YY; Li BR; Ning BT
    Front Immunol; 2020; 11():2033. PubMed ID: 32922406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV.
    Liu J; Zheng X; Tong Q; Li W; Wang B; Sutter K; Trilling M; Lu M; Dittmer U; Yang D
    J Med Virol; 2020 May; 92(5):491-494. PubMed ID: 32056249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection.
    Delgado-Roche L; Mesta F
    Arch Med Res; 2020 Jul; 51(5):384-387. PubMed ID: 32402576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of pathological changes and pathogenic mechanisms caused by H1N1 influenza virus, highly pathogenic H5N1 avian influenza virus, SARS-CoV, MERS-CoV and 2019-nCoV].
    Liu M; Feng RE; Li Q; Zhang HK; Wang YG
    Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):511-516. PubMed ID: 32392945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
    Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
    Front Immunol; 2020; 11():581338. PubMed ID: 33123167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system.
    Coperchini F; Chiovato L; Croce L; Magri F; Rotondi M
    Cytokine Growth Factor Rev; 2020 Jun; 53():25-32. PubMed ID: 32446778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines and COVID-19: friends or foes?
    Rokni M; Hamblin MR; Rezaei N
    Hum Vaccin Immunother; 2020 Oct; 16(10):2363-2365. PubMed ID: 32841579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019].
    Zhang T; Sun LX; Feng RE
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Jun; 43(6):496-502. PubMed ID: 32241072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covid-19: Perspectives on Innate Immune Evasion.
    Taefehshokr N; Taefehshokr S; Hemmat N; Heit B
    Front Immunol; 2020; 11():580641. PubMed ID: 33101306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets.
    Karmouty-Quintana H; Thandavarayan RA; Keller SP; Sahay S; Pandit LM; Akkanti B
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33138181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine release syndrome in severe COVID-19.
    Moore JB; June CH
    Science; 2020 May; 368(6490):473-474. PubMed ID: 32303591
    [No Abstract]   [Full Text] [Related]  

  • 13. Remdesivir against COVID-19 and Other Viral Diseases.
    Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
    Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How to understand the histopathology of SARS and coronavirus disease-19 (COVID-19) associated with acute respiratory distress syndrome].
    Chen J
    Zhonghua Bing Li Xue Za Zhi; 2020 Apr; 49(4):289-290. PubMed ID: 32157847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
    van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
    Elife; 2020 Apr; 9():. PubMed ID: 32338605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases.
    Rossi GA; Sacco O; Mancino E; Cristiani L; Midulla F
    Infection; 2020 Oct; 48(5):665-669. PubMed ID: 32737833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS.
    Lupu L; Palmer A; Huber-Lang M
    Front Immunol; 2020; 11():584514. PubMed ID: 33101314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?
    Liu B; Li M; Zhou Z; Guan X; Xiang Y
    J Autoimmun; 2020 Jul; 111():102452. PubMed ID: 32291137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin-Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome.
    Hrenak J; Simko F
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19: Underlying Adipokine Storm and Angiotensin 1-7 Umbrella.
    Méry G; Epaulard O; Borel AL; Toussaint B; Le Gouellec A
    Front Immunol; 2020; 11():1714. PubMed ID: 32793244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.